Hepatosplenic T-cell Lymphoma
Oncology·MeSH: Lymphoma, T-Cell, Cutaneous
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Hepatosplenic T-cell Lymphoma?
There are 1 clinical trial targeting Hepatosplenic T-cell Lymphoma tracked by BioSniper.
What is the prevalence of Hepatosplenic T-cell Lymphoma?
The estimated prevalence of Hepatosplenic T-cell Lymphoma is approximately 56.0 per 100,000 population.
Deep-dive into Hepatosplenic T-cell Lymphoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis